1. Home
  2. ONC vs NTR Comparison

ONC vs NTR Comparison

Compare ONC & NTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • NTR
  • Stock Information
  • Founded
  • ONC 2010
  • NTR 2017
  • Country
  • ONC Switzerland
  • NTR Canada
  • Employees
  • ONC N/A
  • NTR N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • NTR Agricultural Chemicals
  • Sector
  • ONC Health Care
  • NTR Industrials
  • Exchange
  • ONC Nasdaq
  • NTR Nasdaq
  • Market Cap
  • ONC 31.5B
  • NTR 30.3B
  • IPO Year
  • ONC N/A
  • NTR N/A
  • Fundamental
  • Price
  • ONC $299.01
  • NTR $58.56
  • Analyst Decision
  • ONC Strong Buy
  • NTR Hold
  • Analyst Count
  • ONC 9
  • NTR 17
  • Target Price
  • ONC $332.44
  • NTR $61.88
  • AVG Volume (30 Days)
  • ONC 411.4K
  • NTR 1.7M
  • Earning Date
  • ONC 08-06-2025
  • NTR 08-06-2025
  • Dividend Yield
  • ONC N/A
  • NTR 3.71%
  • EPS Growth
  • ONC N/A
  • NTR N/A
  • EPS
  • ONC N/A
  • NTR 1.06
  • Revenue
  • ONC $4,175,868,000.00
  • NTR $24,739,000,000.00
  • Revenue This Year
  • ONC $865.19
  • NTR $6.07
  • Revenue Next Year
  • ONC $21.12
  • NTR $1.03
  • P/E Ratio
  • ONC N/A
  • NTR $55.12
  • Revenue Growth
  • ONC 51.16
  • NTR N/A
  • 52 Week Low
  • ONC $155.75
  • NTR $43.70
  • 52 Week High
  • ONC $308.87
  • NTR $65.08
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • NTR 43.10
  • Support Level
  • ONC N/A
  • NTR $59.14
  • Resistance Level
  • ONC N/A
  • NTR $60.47
  • Average True Range (ATR)
  • ONC 0.00
  • NTR 1.09
  • MACD
  • ONC 0.00
  • NTR -0.16
  • Stochastic Oscillator
  • ONC 0.00
  • NTR 18.76

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About NTR Nutrien Ltd.

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

Share on Social Networks: